Principle Investigator (Vancouver Site):
Dr. Kristin Campbell
Principle Investigator (Ottawa Site):
Dr. Jennifer Brunet
Research Coordinator (Vancouver Site):
Kylie Sullivan, MSc
Purpose:
The aim of the ACTIVATE trial is to evaluate the impact of a supervised aerobic exercise intervention on chemotherapy-related cognitive changes (CRCC) in women diagnosed with early stage breast cancer. Chemotherapy-related cognitive changes (CRCC) are reported by up to 75% of breast cancer survivors during treatment and symptoms persist in 35% of survivors after treatment. Aerobic exercise is associated with improved quality of life in breast cancer survivors and holds promise as an intervention to prevent or mitigate CRCC.
Intervention:
The intervention involves 3X weekly supervised aerobic exercise training for 12-16 weeks. All programs are facilitated by staff who have experience working with cancer patients.
If you are a women who is receiving adjuvant chemotherapy and you are interested in participating, please contact Kylie Sullivan at activate.trail@ubc.ca, or 519-803-3658 to gather more information and determine your eligibility for the trial.